Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 13 NIH 10 INDUSTRY 5 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 2 Thoracic 1 Plasma cell 1 Other solid neoplasm 1 Lymphoid 1 Genitourinary 1 Gastrointestinal 1 CNS 1

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1

Interventions

Cyclophosphamide 90 Vincristine 83 Doxorubicin 69 Prednisone 66 Cytarabine 59 Methotrexate 58 Rituximab 49 Etoposide 43 Radiotherapy 41 Dexamethasone 41 Filgrastim 39 Leucovorin 27 Mercaptopurine 26 Granulocyte Colony-Stimulating Factor 26 pegaspargase 22 Calcium Dobesilate 22 Daunorubicin 21 Asparaginase 20 merphos 19 Specimen Handling 18 Thioguanine 17 Hydrocortisone 16 Bleomycin 16 Peripheral Blood Stem Cell Transplantation 14 Vinblastine 13 Gene Expression Profiling 13 Methylprednisolone 12 Ifosfamide 12 Gemcitabine 12 dexamethasone acetate 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Ipilimumab × Lymphoid × Clear all

NCT03297606 2026-03-27

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡